Skip to main content

Table 1 Demographic, clinical, and psychosocial characteristics of the eligible subjects with respect to current GAD as determined by the MINI-Plus 5.0.0

From: Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine

 

Mean ± SD (range) or number (%)

 
 

No GAD

GAD

 

Characteristics

(n = 114)

(n = 32)

p value*

Age, years

40.7 ± 13.0 (16–65)

37.3 ± 12.8 (17–61)

0.195

Gender, female

101 (88.6)

25 (78.1)

0.128

Education, years

12.9 ± 2.8 (5–18)

12.8 ± 2.8 (6–16)

0.877

Job, yes

45 (39.5)

15 (46.9)

0.452

Household income, at least 3 million KRW/month

77 (67.5)

19 (59.4)

0.390

Married without divorce or bereavement

72 (63.2)

18 (56.3)

0.478

Age at onset, years

30.5 ± 12.3 (8–59)

29.1 ± 12.6 (11–54)

0.570

Disease duration, years

10.2 ± 8.3 (0–36)

8.3 ± 7.9 (1–33)

0.239

Attack frequency/3 months

16.0 ± 18.5 (1–90)

22.8 ± 24.9 (3–90)

0.160

Attack duration, hours

26.4 ± 21.8 (4–72)

30.1 ± 21.7 (4–72)

0.395

Migraine chronicity, chronic

64 (56.1)

20 (62.5)

0.520

Family history of migraine

70 (61.4)

21 (65.6)

0.663

Photophobia

49 (43.0)

18 (56.3)

0.183

Phonophobia

67 (58.8)

26 (81.3)

0.019

Osmophobia

55 (48.2)

17 (53.1)

0.626

GAD-7 score

3.7 ± 3.4 (0–15)

10.2 ± 5.4 (1–21)

<0.001

BAI score

9.8 ± 7.1 (0–35)

25.3 ± 14.7 (2–56)

<0.001

MIDAS, day

23.0 ± 29.3 (0–190)

36.5 ± 41.3 (0–183)

0.092

HIT-6 score

57.7 ± 7.6 (40–72)

63.9 ± 6.3 (48–78)

<0.001

MSQoL

70.1 ± 15.3 (34–94)

54.8 ± 15.3 (26–85)

<0.001

  1. GAD Generalized Anxiety Disorder, MINI-Plus 5.0.0 Mini International Neuropsychiatric Interview-Plus Version 5.0.0, KRW Korean Won, GAD-7 Generalized Anxiety Disorder-7, BAI Beck Anxiety Inventory, MIDAS Migraine Disability Assessment Scale, HIT-6 Headache Impact Test-6, MSQoL Migraine-Specific Quality of Life
  2. *Independent t-test or chi-square tests were performed for the comparison of variables